Bioengineers at Duke University of Durham, North Carolina, USA, have developed a self-assembling nanomaterial that can help limit the damage caused by inflammatory diseases by activating key cells in the immune system.
In mouse models of psoriasis, the nanofibre-based drug mitigated damaging inflammation as effectively as a gold-standard therapy.
For the full story, see the May 2021 edition of Smart Textiles & Wearables.